Build compliant, reusable, channel-agnostic content at scale,
delivered faster, smarter, and more efficiently than ever before.
Content often fails to engage when not tailored to HCP or patient preferences.
Heavy reliance on external partners increases costs and slows execution.
Repeated reviews and reworks delay approvals and hinder scale.
Valuable assets are rebuilt instead of efficiently repurposed across markets.
Inefficient processes lead to missed moments of engagement.
Content operations struggle to keep pace with global demands.
Experience GenAI-Powered Authoring for the Modern Pharma Enterprise.
Author once, adapt everywhere, and accelerate compliant content creation at scale.
Channel-agnostic content
RTE and HCP emails
Interactive e-Detailers
AI intelligence content
Static & dynamic ads
AI-powered visuals
Powered by a GenAI-driven foundation, NCCA transforms how pharma organizations create and scale content.
Spark strategic ideas with AI-driven planning and creative conceptualization.
Transform ideas into high-impact assets with AI-powered creation and modular workflows.
Localize with precision and tailor content to personas, markets, and cultures.
Measure what matters with AI-powered insights for continuous optimization.
Ensure compliant content with AI-driven MLR validation and built-in guardrails.
Accelerated timelines from concept to market-ready materials
Reduced operational expenses through automated processes
Enhanced asset utilisation across markets and channels
0of the Top0Pharma companies already trust NCCA to transform their content operations
Get started within days, not months. Our expert implementation team ensures smooth integration with your existing systems and workflows.
Comprehensive training programs for all user levels, from content creators to compliance teams, ensuring maximum adoption and success.
24/7 technical support, regular updates, and dedicated customer success management to ensure continued optimization of your content operations.
See NCCA in action and discover how leading pharmaceutical companies are accelerating compliant content creation while reducing costs and improving efficiency
